A new study published by the National Institute of Health has found that activation of the body’s cannabinoid receptors can combat skin cancer.
Activiation of the body’s cannabinoid receptors helps with a number of diseases and ailments, including skin cancer according to this new study.
According to researchers at the Department of Pharmacy at the University of Pisa in Italy; “Cannabinoids are implicated in the control of cell proliferation, but little is known about the role of the endocannabinoid system in human malignant melanoma [the deadliest form of skin cancer]. This study was aimed at characterizing the in vitro antitumor activity of anandamide [a naturally occurring cannabinoid]in A375 melanoma cells.”
The study concludes that; “Overall, these findings demonstrate that AEA [anadamide]induces cytotoxicity against human melanoma cells in the micromolar range of concentrations through a complex mechanism, which involves COX-2 and LOX-derived product synthesis and CB1activation”. This demonstrates that activation of the body’s cannabinoid receptors – which cannabis does naturally – has strong anticancer capabilities.
A study released earlier this year found similar results; using cannabinoids on mice, researchers were able to reduce skin cancer by 90% in just 20 weeks.